Cargando…

New aspects in deriving health-based guidance values for bromate in swimming pool water

Bromate, classified as a EU CLP 1B carcinogen, is a typical by-product of the disinfection of drinking and swimming pool water. The aim of this study was (a) to provide data on the occurrence of bromate in pool water, (b) to re-evaluate the carcinogenic MOA of bromate in the light of existing data,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Röhl, C., Batke, M., Damm, G., Freyberger, A., Gebel, T., Gundert-Remy, U., Hengstler, J. G., Mangerich, A., Matthiessen, A., Partosch, F., Schupp, T., Wollin, K. M., Foth, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Regulatory Toxicology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095538/ https://www.ncbi.nlm.nih.gov/pubmed/35386057 http://dx.doi.org/10.1007/s00204-022-03255-9

Ejemplares similares

The EU chemicals strategy for sustainability: critical reflections on proposed regulatory changes for endocrine disruptors and mixture toxicity
por: Batke, M., et al.
Publicado: (2022)

Critical evaluation of human health risks due to hydraulic fracturing in natural gas and petroleum production
por: Wollin, Klaus-Michael, et al.
Publicado: (2020)

Long-term simulation of lead concentrations in agricultural soils in relation to human adverse health effects
por: Schupp, Thomas, et al.
Publicado: (2020)

Sensory irritation as a basis for setting occupational exposure limits
por: Brüning, Thomas, et al.
Publicado: (2014)

Current pesticide dietary risk assessment in light of comparable animal study NOAELs after chronic and short-termed exposure durations
por: Zarn, Jürg A., et al.
Publicado: (2017)

Practical application of the interim internal threshold of toxicological concern (iTTC): a case study based on clinical data
por: Najjar, Abdulkarim, et al.
Publicado: (2022)

A framework for the use of single-chemical transcriptomics data in predicting the hazards associated with complex mixtures of polycyclic aromatic hydrocarbons
por: Labib, Sarah, et al.
Publicado: (2016)

Next generation risk assessment of human exposure to estrogens using safe comparator compound values based on in vitro bioactivity assays
por: van Tongeren, Tessa C. A., et al.
Publicado: (2023)

A framework for chemical safety assessment incorporating new approach methodologies within REACH
por: Ball, Nicholas, et al.
Publicado: (2022)

A new approach to the classification of carcinogenicity
por: Doe, John E., et al.
Publicado: (2022)

Standardisation of defined approaches for skin sensitisation testing to support regulatory use and international adoption: position of the International Cooperation on Alternative Test Methods
por: Casati, S., et al.
Publicado: (2017)

Screening of chemicals for human bioaccumulative potential with a physiologically based toxicokinetic model
por: Tonnelier, Arnaud, et al.
Publicado: (2011)

Predicting in vivo effect levels for repeat-dose systemic toxicity using chemical, biological, kinetic and study covariates
por: Truong, Lisa, et al.
Publicado: (2017)

Recommended approaches in the application of toxicogenomics to derive points of departure for chemical risk assessment
por: Farmahin, Reza, et al.
Publicado: (2016)

Screening of repeated dose toxicity data in safety evaluation reports of cosmetic ingredients issued by the Scientific Committee on Consumer Safety between 2009 and 2019
por: Gustafson, Emma, et al.
Publicado: (2020)

Investigating the effects of differently produced synthetic amorphous silica (E 551) on the integrity and functionality of the human intestinal barrier using an advanced in vitro co-culture model
por: Hempt, Claudia, et al.
Publicado: (2020)

Application of grouping and read-across for the evaluation of parabens of different chain lengths with a particular focus on endocrine properties
por: Fayyaz, Susann, et al.
Publicado: (2021)

Principles of dose-setting in toxicology studies: the importance of kinetics for ensuring human safety
por: Borgert, C. J., et al.
Publicado: (2021)

Integration of data across toxicity endpoints for improved safety assessment of chemicals: the example of carcinogenicity assessment
por: Madia, Federica, et al.
Publicado: (2021)

“Don’t Blast”: blast-in-place (BiP) operations of dumped World War munitions in the oceans significantly increase hazards to the environment and the human seafood consumer
por: Maser, Edmund, et al.
Publicado: (2020)

An approach for mixture testing and prioritization based on common kinetic groups
por: Braeuning, Albert, et al.
Publicado: (2022)

A new conceptional model for deriving average dermal absorption estimates from studies with multiple tested concentrations for non-dietary risk assessment of pesticides
por: Kluxen, Felix M., et al.
Publicado: (2022)

Species differences and human relevance of the toxicity of 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors and a new approach method in vitro for investigation
por: Botham, Jane, et al.
Publicado: (2023)

A mixture of 13 pesticides, contaminants, and food additives below individual NOAELs produces histopathological and organ weight changes in rats
por: Dinca, Viorica, et al.
Publicado: (2023)

Modernizing persistence–bioaccumulation–toxicity (PBT) assessment with high throughput animal-free methods
por: Escher, Beate I., et al.
Publicado: (2023)

Analysis of health concerns not addressed by REACH for low tonnage chemicals and opportunities for new approach methodology
por: Botham, Philip, et al.
Publicado: (2023)

Oral nicotine pouches with an aftertaste? Part 1: screening and initial toxicological assessment of flavorings and other ingredients
por: Mallock-Ohnesorg, Nadja, et al.
Publicado: (2023)

Oral nicotine pouches with an aftertaste? Part 2: in vitro toxicity in human gingival fibroblasts
por: Rinaldi, Selina, et al.
Publicado: (2023)

Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A
por: Hengstler, JG, et al.
Publicado: (2011)

In Vitro–In Vivo Extrapolation by Physiologically Based Kinetic Modeling: Experience With Three Case Studies and Lessons Learned
por: Algharably, Engi Abdelhady, et al.
Publicado: (2022)

Drug Lag and Key Regulatory Barriers in the Emerging Markets
por: Wileman, Harriet, et al.
Publicado: (2010)

Regulations and guidelines governing stem cell based products: Clinical considerations
por: George, Bobby
Publicado: (2011)

Regulatory Considerations for Biosimilars
por: Nellore, Ranjani
Publicado: (2010)

Registration of Medical Devices
por: George, Bobby
Publicado: (2010)

Implications of ICH-E5: Assessment of drug's sensitivity to ethnic factors and necessity of a bridging study for global drug development
por: Gupta, Sandeep Kumar
Publicado: (2011)

Regulatory requirements for marketing fixed dose combinations
por: Jayasheel, B. G.
Publicado: (2010)

Injury and death in clinical trials and compensation: Rule 122 DAB
por: Ghooi, Ravindra. B.
Publicado: (2013)

Key points of technical review for the registration of SARS-CoV-2 antigen/antibody tests
por: Li, Hongran, et al.
Publicado: (2021)

China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval
por: Lv, Yunfeng, et al.
Publicado: (2020)

Key points of technical review for the registration of SARS-CoV-2 nucleic acid tests in China
por: Li, Hongran, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sd303nt1vc5v1rse1u9249fdi2